How Allergy Sufferers Can Benefit from Immunotherapy

StreetInsider

2023-08-23

The Centers for Disease Control and Prevention (CDC) estimates that close to one in three adults and more than one in every four children in America have a food allergy, seasonal allergy or eczema. Close to 6% of children and adults in the country have a food allergy and 25.7% of U.S. adults have a seasonal allergy, 7.3% have eczema, and 6.2% report having a food allergy.

Common allergy treatment approaches include medications to minimize immune system reaction and alleviate symptoms, epinephrine in emergencies and…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) are available in the company’s newsroom at https://ibn.fm/BVXV

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)San Francisco, Californiawww.biomedwire.com415.949.5050 Office[email protected]

BioMedWire is part of the InvestorBrandNetwork.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2361970696"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2361970696\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2361970696?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-08-23 04:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2361970696","market":"us","top_or_hot":-1,"title":"How Allergy Sufferers Can Benefit from Immunotherapy","media":"StreetInsider","content":"<html><body><div>\n<article slug=\"nnwire-2023-8-22-how-allergy-sufferers-can-benefit-from-immunotherapy\"><p>The Centers for Disease Control and Prevention (CDC) estimates that close to one in three adults and more than one in every four children in America have a food allergy, seasonal allergy or eczema. Close to 6% of children and adults in the country have a food allergy and 25.7% of U.S. adults have a seasonal allergy, 7.3% have eczema, and 6.2% report having a food allergy.</p>\n<p>Common allergy treatment approaches include medications to minimize immune system reaction and alleviate symptoms, epinephrine in emergencies and…</p>\n<p>Read More&gt;&gt;</p>\n<p><strong>NOTE TO INVESTORS:</strong> The latest news and updates relating to BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) are available in the company’s newsroom at https://ibn.fm/BVXV</p>\n<p><strong>About BioMedWire</strong></p>\n<p>BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.</p><div><div><div></div></div></div>\n<p>To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)</p>\n<p>For more information, please visit https://www.biomedwire.com</p>\n<p>Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer</p>\n<p>BioMedWire (BMW)San Francisco, Californiawww.biomedwire.com415.949.5050 Office<span>[email protected]</span></p>\n<p>BioMedWire is part of the InvestorBrandNetwork.</p><img height=\"1\" referrerpolicy=\"unsafe-url\" src=\"https://tracking.newsrpm.com/pixel?slug=nnwire-2023-8-22-how-allergy-sufferers-can-benefit-from-immunotherapy\" width=\"1\"/></article> </div></body></html>","source":"highlight_streetinsider","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>How Allergy Sufferers Can Benefit from Immunotherapy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHow Allergy Sufferers Can Benefit from Immunotherapy\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">StreetInsider</strong><span class=\"h-time small\">2023-08-23 04:10</span>\n</p>\n</h4>\n</header>\n<article>\n<html><body><div>\n<article slug=\"nnwire-2023-8-22-how-allergy-sufferers-can-benefit-from-immunotherapy\"><p>The Centers for Disease Control and Prevention (CDC) estimates that close to one in three adults and more than one in every four children in America have a food allergy, seasonal allergy or eczema. Close to 6% of children and adults in the country have a food allergy and 25.7% of U.S. adults have a seasonal allergy, 7.3% have eczema, and 6.2% report having a food allergy.</p>\n<p>Common allergy treatment approaches include medications to minimize immune system reaction and alleviate symptoms, epinephrine in emergencies and…</p>\n<p>Read More&gt;&gt;</p>\n<p><strong>NOTE TO INVESTORS:</strong> The latest news and updates relating to BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) are available in the company’s newsroom at https://ibn.fm/BVXV</p>\n<p><strong>About BioMedWire</strong></p>\n<p>BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.</p><div><div><div></div></div></div>\n<p>To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)</p>\n<p>For more information, please visit https://www.biomedwire.com</p>\n<p>Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer</p>\n<p>BioMedWire (BMW)San Francisco, Californiawww.biomedwire.com415.949.5050 Office<span>[email protected]</span></p>\n<p>BioMedWire is part of the InvestorBrandNetwork.</p><img height=\"1\" referrerpolicy=\"unsafe-url\" src=\"https://tracking.newsrpm.com/pixel?slug=nnwire-2023-8-22-how-allergy-sufferers-can-benefit-from-immunotherapy\" width=\"1\"/></article> </div></body></html>\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://www.streetinsider.com/dr/news.php?id=22075799\">StreetInsider</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4207","symbol_name":"綜合性銀行","start_time":0,"source_url":"https://www.streetinsider.com/dr/news.php?id=22075799","article_id":"2361970696","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2361970696","pubTimestamp":1692735000,"columns":[],"sourceInfo":{"source_id":"highlight_streetinsider","name":"StreetInsider"},"weMediaInfo":null,"summary":"The Centers for Disease Control and Prevention  estimates that close to one in three adults and more than one in every four children in America have a food allergy, seasonal allergy or eczema. Close to 6% of children and adults in the country have a food allergy and 25.7% of U.S. adults have a seasonal allergy, 7.3% have eczema, and 6.2% report having a food allergy.Common allergy treatment approaches include medications to minimize immune system reaction and alleviate symptoms, epinephrine in emergencies and…To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 ","collect":0,"end_time":0,"defaultTopTitle":"streetinsider.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4207":"综合性银行","BK4548":"巴美列捷福持仓","LU0066902890.USD":"HSBC GIF INDIAN EQUITY \"AD\" (USD) INC","IE00BYTNYM70.SGD":"PINEBRIDGE INDIA EQUITY \"A5\" (SGD) ACC","IE00B0JY6M65.USD":"PINEBRIDGE INDIA EQUITY \"A\" (USD) ACC","BK4535":"淡马锡持仓","BK4585":"ETF&股票定投概念","BK4523":"印度概念","LU0251143458.SGD":"Fidelity Emerging Markets A-SGD","BK4588":"碎股","SG9999004220.SGD":"Nikko AM Shenton Asia Dividend Equity Fund  SGD","BK4007":"制药","CDC":"VictoryShares US EQ Income Enhanced Volatility Wtd ETF","IBN":"印度工业信贷投资银行","IE00B7N09G41.SGD":"柏瑞印度股票A5CP SGD"},"translate_title":"过敏患者如何从免疫疗法中获益","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BVXV":1,"CDC":1,"IBN":1},"content_text":"The Centers for Disease Control and Prevention (CDC) estimates that close to one in three adults and more than one in every four children in America have a food allergy, seasonal allergy or eczema. Close to 6% of children and adults in the country have a food allergy and 25.7% of U.S. adults have a seasonal allergy, 7.3% have eczema, and 6.2% report having a food allergy.\nCommon allergy treatment approaches include medications to minimize immune system reaction and alleviate symptoms, epinephrine in emergencies and…\nRead More>>\nNOTE TO INVESTORS: The latest news and updates relating to BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) are available in the company’s newsroom at https://ibn.fm/BVXV\nAbout BioMedWire\nBioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.\nTo receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)\nFor more information, please visit https://www.biomedwire.com\nPlease see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer\nBioMedWire (BMW)San Francisco, Californiawww.biomedwire.com415.949.5050 Office[email protected]\nBioMedWire is part of the InvestorBrandNetwork.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}